Investing.com -- Akari Therapeutics PLC (NASDAQ:AKTX) stock gained 7.9% in premarket trading Tuesday after the company released preclinical data showing its novel antibody-drug conjugate AKTX-101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results